TELA Bio (TELA) EBT Growth (3y) (2021 - 2026)
TELA Bio (TELA) EBT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | 4.82% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 61.06% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -2.57% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | 32.11% |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn | 0.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.77% |
| Dec 31, 2025 | 2.74% |
| Sep 30, 2025 | 6.98% |
| Jun 30, 2025 | 3.98% |
| Mar 31, 2025 | -0.11% |
| Dec 31, 2024 | 75.65% |
| Sep 30, 2024 | 2.86% |
| Jun 30, 2024 | 5.03% |
| Mar 31, 2024 | 15.21% |
| Dec 31, 2023 | -17.01% |
| Sep 30, 2023 | -7.81% |
| Jun 30, 2023 | -17.39% |
| Mar 31, 2023 | -11.09% |
| Dec 31, 2022 | -10.82% |
| Sep 30, 2022 | -14.30% |
| Jun 30, 2022 | -28.92% |
| Mar 31, 2022 | -22.41% |
| Dec 31, 2021 | -12.87% |
| Sep 30, 2021 | -58.67% |